Gene · 4481
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multiplexed strategies toward clinical translation of extracellular vesicles. | Theranostics | 2022 | 36185609 | PubTator, text mining | PubMed |
| Lymph node recurrence and re-excision after primary tumor resection of a histiocytic sarcoma of duodenal origin: a case report. | Surg Case Rep | 2022 | 36182996 | PubTator, text mining | PubMed |
| Identification of molecular subtypes based on inflammatory response in lower-grade glioma. | Inflamm Regen | 2022 | 36180938 | PubTator, text mining | PubMed |
| Novel macrophage-related gene prognostic index for glioblastoma associated with M2 macrophages and T cell dysfunction. | Front Immunol | 2022 | 36177003 | PubTator, text mining | PubMed |
| The role of lipid metabolism in tumor immune microenvironment and potential therapeutic strategies. | Front Oncol | 2022 | 36172157 | PubTator, text mining | PubMed |
| Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis. | Front Pharmacol | 2022 | 36160452 | PubTator, text mining | PubMed |
| [The Analysis of Tumor Immune Microenvironment in Muscle-Invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy]. | Gan To Kagaku Ryoho | 2022 | 36156005 | PubTator, text mining | PubMed |
| Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease. | EBioMedicine | 2022 | 36155958 | PubTator, text mining | PubMed |
| Higher fasting blood glucose was associated with worse in-hospital clinical outcomes in patients with primary intracerebral hemorrhage: From a large-scale nationwide longitudinal registry. | CNS Neurosci Ther | 2022 | 36152306 | PubTator, text mining | PubMed |
| Crosstalk between tumor-associated macrophages and tumor cells promotes chemoresistance via CXCL5/PI3K/AKT/mTOR pathway in gastric cancer. | Cancer Cell Int | 2022 | 36151545 | PubTator, text mining | PubMed |
| Novel Role of CETP in Macrophages: Reduction of Mitochondrial Oxidants Production and Modulation of Cell Immune-Metabolic Profile. | Antioxidants (Basel) | 2022 | 36139808 | PubTator, text mining | PubMed |
| Olanzapine Ameliorates Ischemic Stroke-like Pathology in Gerbils and H2O2-Induced Neurotoxicity in SH-SY5Y Cells via Inhibiting the MAPK Signaling Pathway. | Antioxidants (Basel) | 2022 | 36139770 | PubTator, text mining | PubMed |
| SPP1 Derived from Macrophages Is Associated with a Worse Clinical Course and Chemo-Resistance in Lung Adenocarcinoma. | Cancers (Basel) | 2022 | 36139536 | PubTator, text mining | PubMed |
| Proteomics Identifies Substrates and a Novel Component in hSnd2-Dependent ER Protein Targeting. | Cells | 2022 | 36139500 | PubTator, text mining | PubMed |
| Deep RNA sequencing of intensive care unit patients with COVID-19. | Sci Rep | 2022 | 36130991 | PubTator, text mining | PubMed |
| Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis. | Cell Rep | 2022 | 36130508 | PubTator, text mining | PubMed |
| Receptor-independent fluid-phase macropinocytosis promotes arterial foam cell formation and atherosclerosis. | Sci Transl Med | 2022 | 36130017 | PubTator, text mining | PubMed |
| Scavenger receptor-targeted plaque delivery of microRNA-coated nanoparticles for alleviating atherosclerosis. | Proc Natl Acad Sci U S A | 2022 | 36122215 | PubTator, text mining | PubMed |
| Immunotherapy resistance in esophageal cancer: Possible mechanisms and clinical implications. | Front Immunol | 2022 | 36119033 | PubTator, text mining | PubMed |
| Peroxidase is a novel potential marker in glioblastoma through bioinformatics method and experimental validation. | Front Genet | 2022 | 36118855 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4481/papers?page=42